Journey Medical (DERM) Change in Inventory (2020 - 2026)
Journey Medical (DERM) posted Change in Inventory of -$332000.0 for Q1 2026, up 84.87% on a QoQ basis from -$2.2 million in Q4 2025, and up 82.84% year-over-year from -$181577.2 in Q1 2025.
Journey Medical (DERM) Change in Inventory (2020 - 2026) Analysis & Trends
Journey Medical's Change in Inventory history runs 7 years deep, the most recent figure standing at -$332000.0 for Q1 2026.
- Quarterly Change in Inventory rose 82.84% year-over-year to -$332000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.2 million (down 267.22% YoY) and the FY2025 annual result came in at -$4.8 million, down 213.78% from the prior year.
- Change in Inventory was -$332000.0 for Q1 2026 at Journey Medical, up from -$2.2 million in the prior quarter.
- Across five years, Change in Inventory topped out at $2.6 million in Q4 2024 and bottomed at -$2.2 million in Q4 2025.
- A 5-year average of -$388882.4 and a median of -$823000.0 in 2022 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory slumped 1223.81% — and 2024, when it surged 423.11%.
- Journey Medical's Change in Inventory stood at -$1.1 million in 2022, then grew by 23.62% to -$818000.0 in 2023, then jumped by 423.11% to $2.6 million in 2024, then tumbled by 183.01% to -$2.2 million in 2025, then surged by 84.87% to -$332000.0 in 2026.
- Business Quant data shows DERM's Change in Inventory at -$332000.0 in Q1 2026, -$2.2 million in Q4 2025, and -$1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | -332,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -332,000.00 |
| Mar 31, 2026 | -332,000.00 |
| Dec 31, 2025 | -2.19 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Sep 30, 2025 | -1.03 Mn |
| Sep 30, 2025 | -1.03 Mn |
| Jun 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 356,000.00 |
| Mar 31, 2025 | -1.94 Mn |
| Mar 31, 2025 | -1.94 Mn |
| Dec 31, 2024 | 2.64 Mn |
| Dec 31, 2024 | 2.64 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | -893,000.00 |
| Jun 30, 2024 | -893,000.00 |
| Mar 31, 2024 | 374,000.00 |
| Mar 31, 2024 | 374,000.00 |
| Dec 31, 2023 | -818,000.00 |
| Dec 31, 2023 | -818,000.00 |